Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
64800
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status report for Series 6 Stock Acquisition Rights with an exercise price adjustment clause and Series 7 Stock Acquisition Rights with an exercise price adjustment clause issued through a third-party allotment
発行・処分する株式数
Series 6: 64,800 shares delivered during the applicable month (64,800 new shares; no transfer of treasury shares stated); Series 7: 0 shares
Intended allottee
株式会社ＳＢＩ証券 and 東海東京証券株式会社 (reporting the monthly exercise status in this report)
発行済株式総数
Exercise ratio subject to exercise restrictions: 0.52%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Series 6: The exercise price in September 2026 was ¥1,024–¥1,097 per share. Series 7: No exercise during the subject month. Details of the adjustment provisions: Not disclosed
Number of Stock Acquisition Rights
Series 6: Total issued, 7,500; unexercised at the end of the month preceding the subject month, 7,230; unexercised at the end of the subject month, 6,582. Series 7: Total issued, 7,500; unexercised at the end of the month preceding the subject month, 7,500; unexercised at the end of the subject month, 7,500
Offering structure
Underwriter / lead underwriter
SBI SECURITIES Co., Ltd. and Tokai Tokyo Securities Co., Ltd.
Procedures under the Corporate Code of Conduct
Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments and Other Transactions
Most recent equity financing
Timing 24 August 2026 / Type Third-party allotment of Series 6 stock acquisition rights (with an exercise price adjustment provision) and Series 7 stock acquisition rights (with an exercise price adjustment provision) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status report for Series 6 Stock Acquisition Rights with an exercise price adjustment clause and Series 7 Stock Acquisition Rights with an exercise price adjustment clause issued through a third-party allotment |
| Number of shares to be issued or disposed of | Series 6: 64,800 shares delivered during the applicable month (64,800 new shares; no transfer of treasury shares stated); Series 7: 0 shares |
| Intended allottee | 株式会社ＳＢＩ証券 and 東海東京証券株式会社 (reporting the monthly exercise status in this report) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 0.52% |
| Total number of issued shares | 12,544,400 shares (as of the end of the month preceding the subject month; including 90,153 treasury shares) → Not disclosed |
| Exercise price | Series 6: The exercise price in September 2026 was ¥1,024–¥1,097 per share. Series 7: No exercise during the subject month. Details of the adjustment provisions: Not disclosed |
| Number of Stock Acquisition Rights | Series 6: Total issued, 7,500; unexercised at the end of the month preceding the subject month, 7,230; unexercised at the end of the subject month, 6,582. Series 7: Total issued, 7,500; unexercised at the end of the month preceding the subject month, 7,500; unexercised at the end of the subject month, 7,500 |
| Underwriter / lead underwriter | SBI SECURITIES Co., Ltd. and Tokai Tokyo Securities Co., Ltd. |
| Procedures under the Corporate Code of Conduct | Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments and Other Transactions |
| Most recent equity financing | Timing 24 August 2026 / Type Third-party allotment of Series 6 stock acquisition rights (with an exercise price adjustment provision) and Series 7 stock acquisition rights (with an exercise price adjustment provision) / Amount Not disclosed |
Items this document does not state (18)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in September 2026 of the Series 6 and Series 7 Stock Acquisition Rights issued on 24 August 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.